Last updated on May 2019

Assessing the Ability of the T-SPOT .TB Test


Brief description of study

The primary objective of this clinical research study is to demonstrate performance of the normalized TB specific lymphocyte response in identifying patients with active TB disease. The secondary exploratory objective is to demonstrate that active TB cannot be identified using an antigen-to-mitogen ratio derived from an ELISA-based IGRA.

Detailed Study Description

The target number of subjects is 100 active TB and 100 active TB excluded . This study will enroll up to 235 subjects (assumes 15 % exclusion/drop-out rate).

Study Duration: 6 months

All subjects enrolled in this study will be men or women, aged 18 years or older.

Clinical Study Identifier: NCT03929705

Find a site near you

Start Over

University of Cape Town

Cape Town, South Africa
0.23miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.